70 mg/dL group was on statins.
55 mg/dL group was on statins + ezetimibe
#ezpaveHD #ezetimibeHD #statinsHD #statinsezetimibeHD
Hot off the press from the New England Journal of Medicine, and the “LDL doesn’t matter” crowd needs to see this.
Researchers just published a landmark randomized trial involving over 3,000 patients who already had established heart disease. They split them into two groups, one targeting LDL below 70 mg/dL (the conventional goal), and one targeting LDL below 55 mg/dL (the more intensive goal).
The result? The group that pushed LDL lower had a 33% reduction in major cardiovascular events, ie heart attacks, strokes, emergency revascularizations, cardiovascular death, in just 3 years. 9.7% of the conventional group had a serious event. Only 6.6% in the intensive group.
And very importantly, both groups were already being treated. This wasn’t treated vs. untreated. This was “lower LDL” vs. “even lower LDL”, and even lower won. Decisively.
And safety was essentially identical between groups.
How would those who continue to insist that LDL is irrelevant, that it’s all metabolic health, or inflammation, or seed oils, or that cholesterol is “there to heal the lining”, explain this?
If LDL doesn’t matter, why would pushing it from 66 down to 56, a difference of just 10 points, with no other real changes, prevent nearly 1 in 3 major cardiac events?
The evidence here isn’t evolving. It’s been consistent for decades. Lower LDL almost always will = fewer heart attacks and strokes. Period.
OF COURSE, work on all those other things too whenever present, but please stop telling people to ignore their LDLs.
